Graeme Sullivan

Graeme Sullivan is a Lecturer in the School of Pharmacy and Biomolecular Sciences at RCSI. He holds a Ph.D. in Molecular Biology from Trinity College Dublin (2018) and has held postdoctoral positions in Prof. Martin's lab (TCD) and Prof. Ní Chonghaile's Targeted Therapeutics in Cancer (TTC) group at RCSI. His research focuses on cancer biology, immunology, and inflammation with particular emphasis on cytokine signaling (IL-36/IL-37 families), drug resistance mechanisms, and targeted therapies.

Education:

• B.A. B.Dent.Sc. (Hons), Trinity College Dublin (2006)
• P.G. Dip. (Dent. Ed.), University of Bristol (2017)
• Ph.D. in Molecular Biology, Trinity College Dublin (2018)

Research Interests:

• Cancer stem cells and microenvironment interactions
• Mechanisms of venetoclax resistance in hematological malignancies
• PROTAC technology for HDAC6 degradation
• IL-36/IL-37 cytokine activation pathways in inflammatory diseases
• Public Patient Involvement (PPI) in multiple myeloma research

Grants & Awards:

• Irish Cancer Society Translational Fellowship (2021-2024)
• Irish Research Council Grant (2013-2017)
• Edmund Burke Entrance Exhibition Award

Teaching:

• Lecturer in Pharmacy, Medicine, and Physician Associate programs
• Uses innovative pedagogical techniques in classroom and lab settings
• Supervises undergraduate/postgraduate students and serves on academic committees

Labs & Affiliations:

• Current: Targeted Therapeutics in Cancer (TTC) group at RCSI
• Prior: Prof. Martin's Molecular Cell Biology Lab (TCD)
• Member of Athena SWAN committee
• Collaborations with Multiple Myeloma Ireland